Funmbi Babalola
London, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Prolonged neonatal phosphate retention and transient hypercalcemia following antenatal Burosumab exposure: a pharmacovigilance alert.
Journal: Therapeutic advances in drug safety
Published: November 16, 2025
Adolescents With Type 1 Diabetes Using Dapagliflozin as an Adjunct-to-Insulin: Perspectives on Experiences of Clinical Trial Participation.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: November 05, 2025
Optimizing Care for Growth and Puberty in Duchenne Muscular Dystrophy: A Survey of Clinical Practice in the OPTIMIZE DMD Consortium.
Journal: Muscle & nerve
Published: September 04, 2025
Toward lean body weight- and ECV-based dosing of burosumab: eliminating apparent sex differences in XLH therapy.
Journal: Pediatric nephrology (Berlin, Germany)
Published: May 03, 2025
Metabolic and other morbid complications in congenital generalized lipodystrophy type 4.
Journal: American journal of medical genetics. Part A
Published: October 08, 2023
Bone health in young adults with type 1 diabetes and progressive eGFR decline.
Journal: Clinical diabetes and endocrinology
Published: September 25, 2023
Successful treatment of severe hypertriglyceridemia with icosapent ethyl in a case of congenital generalized lipodystrophy type 4.
Journal: Journal of pediatric endocrinology & metabolism : JPEM
Published: November 30, 2021
Why did I stop growing? A case of halted puberty.
Journal: Paediatrics & child health
Published: January 08, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026